NSG 550 exam 3
Magnetic Resonance Imaging; a medical
imaging technique that uses magnetic
MRI
fields and radio waves to create detailed
images of the body.
Magnetic Resonance Angiography; a
specialized type of MRI specifically de-
MRA
signed to image blood vessels and blood
flow.
Ordered when provider suspects spinal
cord or brain injuries, joint problems, lig-
aments, tendons and muscles, tumors,
certain neurological issues, bone infec-
MRI Uses
tions, headaches with neuro symptoms,
suspicion of a fracture after injury, or
when neuro symptoms such as numb-
ness, weakness or tingling are present.
Used for stroke or transient ischemic at-
tack, heart disease to assess the vessels
MRA Uses
of the heart, or to plan a procedure like
stent placement.
A standardized system used to classify
Bethesda Result thyroid nodules based on fine needle as-
piration (FNA) biopsy results.
Nondiagnostic/Unsatisfactory; sample is
Bethesda Category I
inadequate for diagnosis.
Benign; cells appear normal with low
Bethesda Category II
risk.
Atypia of Undetermined Significance
(AUS) or Follicular Lesion of Undeter-
mined Significance (FLUS); cells show
Bethesda Category III
some abnormalities, but it is unclear if
they are cancerous, requiring further in-
vestigation.
Follicular Neoplasm (FN) or Suspicious
Bethesda Category IV
for Follicular Neoplasm (SFN); cells sug-
1/8
, NSG 550 exam 3
gest possible follicular tumor, which
could be benign or cancerous.
Suspicious for Malignancy; cells show
strong evidence of cancer, but further
Bethesda Category V
testing may be needed to confirm diag-
nosis.
Bethesda Category VI Malignant; cells are clearly cancerous.
Cervical Screening Negative Result HPV not detected; retest in 5 years.
Lab needs to do more tests to find out
your level of risk for your HPV type(s);
Cervical Screening Positive for HPV (not
Intermediate Risk = Repeat test in 12
16/18)
months; Higher Risk = GYN refers you to
have colposcopy.
Cervical Screening Positive for HPV You have the virus present; GYN will refer
(16/18) you for a colposcopy.
Cervical Screening Unsatisfactory Re- Not enough data to confirm/refute diag-
sult nosis; repeat test in 6-12 weeks.
When used with contrast material en-
hances the visibility of tumors, inflamma-
MRI Contrast Use
tion, certain organs, blood supply, and
blood vessels.
Useful tool for detecting brain conditions
such as aneurysms, multiple sclero-
sis, spinal cord injuries, hydrocephalus,
MRI Brain Conditions stroke, infections, tumors, swelling, hor-
monal disorders such as acromegaly
and Cushing's Syndrome, hemorrhage,
inflammation, and Chiari malformation.
Used to evaluate suspicious findings on
mammograms, especially in cases of
MRI for Mammograms
dense breast tissue or when cancer is
not visible with other imaging methods.
2/8
Magnetic Resonance Imaging; a medical
imaging technique that uses magnetic
MRI
fields and radio waves to create detailed
images of the body.
Magnetic Resonance Angiography; a
specialized type of MRI specifically de-
MRA
signed to image blood vessels and blood
flow.
Ordered when provider suspects spinal
cord or brain injuries, joint problems, lig-
aments, tendons and muscles, tumors,
certain neurological issues, bone infec-
MRI Uses
tions, headaches with neuro symptoms,
suspicion of a fracture after injury, or
when neuro symptoms such as numb-
ness, weakness or tingling are present.
Used for stroke or transient ischemic at-
tack, heart disease to assess the vessels
MRA Uses
of the heart, or to plan a procedure like
stent placement.
A standardized system used to classify
Bethesda Result thyroid nodules based on fine needle as-
piration (FNA) biopsy results.
Nondiagnostic/Unsatisfactory; sample is
Bethesda Category I
inadequate for diagnosis.
Benign; cells appear normal with low
Bethesda Category II
risk.
Atypia of Undetermined Significance
(AUS) or Follicular Lesion of Undeter-
mined Significance (FLUS); cells show
Bethesda Category III
some abnormalities, but it is unclear if
they are cancerous, requiring further in-
vestigation.
Follicular Neoplasm (FN) or Suspicious
Bethesda Category IV
for Follicular Neoplasm (SFN); cells sug-
1/8
, NSG 550 exam 3
gest possible follicular tumor, which
could be benign or cancerous.
Suspicious for Malignancy; cells show
strong evidence of cancer, but further
Bethesda Category V
testing may be needed to confirm diag-
nosis.
Bethesda Category VI Malignant; cells are clearly cancerous.
Cervical Screening Negative Result HPV not detected; retest in 5 years.
Lab needs to do more tests to find out
your level of risk for your HPV type(s);
Cervical Screening Positive for HPV (not
Intermediate Risk = Repeat test in 12
16/18)
months; Higher Risk = GYN refers you to
have colposcopy.
Cervical Screening Positive for HPV You have the virus present; GYN will refer
(16/18) you for a colposcopy.
Cervical Screening Unsatisfactory Re- Not enough data to confirm/refute diag-
sult nosis; repeat test in 6-12 weeks.
When used with contrast material en-
hances the visibility of tumors, inflamma-
MRI Contrast Use
tion, certain organs, blood supply, and
blood vessels.
Useful tool for detecting brain conditions
such as aneurysms, multiple sclero-
sis, spinal cord injuries, hydrocephalus,
MRI Brain Conditions stroke, infections, tumors, swelling, hor-
monal disorders such as acromegaly
and Cushing's Syndrome, hemorrhage,
inflammation, and Chiari malformation.
Used to evaluate suspicious findings on
mammograms, especially in cases of
MRI for Mammograms
dense breast tissue or when cancer is
not visible with other imaging methods.
2/8
